Summit BHC, a leading national provider of behavioral health and addiction treatment services, has acquired Seabrook, an addiction treatment provider in New Jersey, effective Dec. 21, 2020.
Seabrook’s operations include a 153-bed inpatient treatment facility located on 40 acres in Bridgeton, New Jersey, along with three additional intensive outpatient programs operating in Cherry Hill, Morristown, and Shrewsbury. This acquisition marks Summit’s first entry into New Jersey and brings the company’s total number of facilities to 22 across the United States.
“We are excited to welcome Seabrook to our family of addiction treatment centers,” says Brent Turner, CEO of Summit. “Seabrook is well-established and recognized in the substance use treatment community, and we are committed to carrying on its tradition of providing the highest quality care going forward.”
“Seabrook has a 46-year legacy of helping clients and families recover from alcoholism and substance use problems,” says Edward M. Diehl, president of Seabrook. “Joining the family of Summit BHC allows Seabrook to continue providing our multi-disciplined approach to clients from across the region while partnering with a national provider.”
Mertz Taggart, a leading healthcare services mergers and acquisitions firm, provided sell-side services to Seabrook in this transaction.
To access more business news, visit NJB News Now.Related Articles: